1. Home
  2. NBTX vs DC Comparison

NBTX vs DC Comparison

Compare NBTX & DC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBTX
  • DC
  • Stock Information
  • Founded
  • NBTX 2003
  • DC 2017
  • Country
  • NBTX France
  • DC United States
  • Employees
  • NBTX N/A
  • DC N/A
  • Industry
  • NBTX Biotechnology: Pharmaceutical Preparations
  • DC Precious Metals
  • Sector
  • NBTX Health Care
  • DC Basic Materials
  • Exchange
  • NBTX Nasdaq
  • DC Nasdaq
  • Market Cap
  • NBTX 201.9M
  • DC 211.7M
  • IPO Year
  • NBTX 2020
  • DC N/A
  • Fundamental
  • Price
  • NBTX $3.83
  • DC $2.24
  • Analyst Decision
  • NBTX Strong Buy
  • DC Buy
  • Analyst Count
  • NBTX 2
  • DC 1
  • Target Price
  • NBTX $11.50
  • DC $6.00
  • AVG Volume (30 Days)
  • NBTX 8.8K
  • DC 262.3K
  • Earning Date
  • NBTX 11-26-2024
  • DC 11-13-2024
  • Dividend Yield
  • NBTX N/A
  • DC N/A
  • EPS Growth
  • NBTX N/A
  • DC N/A
  • EPS
  • NBTX N/A
  • DC N/A
  • Revenue
  • NBTX $45,220,186.00
  • DC N/A
  • Revenue This Year
  • NBTX N/A
  • DC N/A
  • Revenue Next Year
  • NBTX N/A
  • DC N/A
  • P/E Ratio
  • NBTX N/A
  • DC N/A
  • Revenue Growth
  • NBTX 526.17
  • DC N/A
  • 52 Week Low
  • NBTX $3.57
  • DC $1.84
  • 52 Week High
  • NBTX $8.96
  • DC $3.25
  • Technical
  • Relative Strength Index (RSI)
  • NBTX 38.67
  • DC 46.78
  • Support Level
  • NBTX $3.57
  • DC $2.12
  • Resistance Level
  • NBTX $4.11
  • DC $2.25
  • Average True Range (ATR)
  • NBTX 0.28
  • DC 0.11
  • MACD
  • NBTX -0.00
  • DC -0.01
  • Stochastic Oscillator
  • NBTX 26.31
  • DC 25.00

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

About DC Dakota Gold Corp.

Dakota Gold Corp is a gold exploration and development company with a specific focus on revitalizing the Homestake District in Lead, South Dakota. Dakota Gold has high-caliber gold mineral properties covering over 48 thousand acres surrounding the historic Homestake Mine.

Share on Social Networks: